Edgewood Management LLC lessened its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 45.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 665,184 shares of the semiconductor company's stock after selling 562,780 shares during the period. Synopsys makes up about 4.6% of Edgewood Management LLC's holdings, making the stock its 9th largest position. Edgewood Management LLC owned 0.35% of Synopsys worth $289,315,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Elevation Wealth Partners LLC lifted its holdings in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC bought a new stake in Synopsys during the 2nd quarter valued at $25,000. IMG Wealth Management Inc. bought a new stake in Synopsys during the 2nd quarter valued at $28,000. GK Wealth Management LLC acquired a new position in Synopsys during the third quarter worth $28,000. Finally, EFG International AG acquired a new position in Synopsys during the second quarter worth $34,000. Institutional investors own 85.47% of the company's stock.
Latest Synopsys News
Investors following SNPS have been watching these news items:
- Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
- Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence
- Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on SNPS. BNP Paribas Exane lifted their price target on Synopsys from $420.00 to $475.00 and gave the company a "neutral" rating in a research note on Thursday, October 1st. Sanford C. Bernstein initiated coverage on shares of Synopsys in a report on Friday, September 25th. They set an "outperform" rating on the stock. Robert W. Baird raised shares of Synopsys from a "neutral" rating to an "outperform" rating and lifted their price objective for the stock from $558.00 to $560.00 in a report on Thursday, August 27th. KeyCorp upped their target price on shares of Synopsys from $600.00 to $605.00 and gave the stock an "overweight" rating in a research note on Thursday, October 1st. Finally, JPMorgan Chase & Co. lowered their target price on shares of Synopsys from $650.00 to $600.00 in a report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $577.71.
Read Our Latest Analysis on Synopsys
Insider Buying and Selling at Synopsys
In other Synopsys news, CFO Sudhindra Kankanwadi sold 9,170 shares of the stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Janet Lee sold 1,144 shares of the stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the sale, the insider directly owned 16,534 shares in the company, valued at $8,308,665.68. This trade represents a 6.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 117,163 shares of company stock valued at $51,366,457 in the last quarter. Corporate insiders own 0.56% of the company's stock.
Synopsys Stock Performance
NASDAQ SNPS opened at $396.55 on Friday. The company has a market capitalization of $76.00 billion, a PE ratio of 70.06, a price-to-earnings-growth ratio of 1.40 and a beta of 1.18. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48. The company has a 50-day simple moving average of $448.46 and a 200 day simple moving average of $440.14.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The business's revenue was up 42.4% on a year-over-year basis. During the same period in the previous year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, research analysts predict that Synopsys, Inc. will post 11.01 EPS for the current year.
Synopsys declared that its Board of Directors has approved a stock repurchase plan on Monday, October 5th that permits the company to repurchase $1 billion in outstanding shares. This buyback authorization permits the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share buyback plans are often a sign that the company's board of directors believes its stock is undervalued.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Recommended Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.